Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid and Hematological Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00005805
What this trial is testing

St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFatigueLeukemia+5 more
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT01053494
What this trial is testing

Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAngioimmunoblastic T-cell Lymphoma+84 more
Wake Forest University Health Sciences 80
Not applicableLooking for participantsNCT05481502
What this trial is testing

An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors

Who this might be right for
Solid Tumor, AdultSolid Tumor, ChildhoodHematologic Cancer
Gustave Roussy, Cancer Campus, Grand Paris 160
Not applicableLooking for participantsNCT03023202
What this trial is testing

UWCCC Molecular Tumor Board Registry

Who this might be right for
Hematologic NeoplasmsSolid Neoplasm
University of Wisconsin, Madison 10,000
Early research (Phase 1)Active Not RecruitingNCT05104775
What this trial is testing

GNC-035, a Tetra-specific Antibody, in Participants With Relapsed/Refractory Hematologic Malignancy

Who this might be right for
Hematologic Malignancies
Sichuan Baili Pharmaceutical Co., Ltd. 33
Not applicableUnknownNCT00300001
What this trial is testing

Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes

Who this might be right for
CancerSolid TumorHematologic Malignancy
Community Cancer Care 300
Not applicableStudy completedNCT02786628
What this trial is testing

Assessing Physical Fitness in Cancer Patients With Cardiopulmonary Exercise Testing and Wearable Data Generation

Who this might be right for
Malignant Solid TumourHematologic MalignanciesPlanned Hematopoietic Cell Transplantation
UNC Lineberger Comprehensive Cancer Center 43
Not applicableStudy completedNCT05790538
What this trial is testing

Predicting the Impact of Treatment Toxicities on Health During Cancer ( PATTERN )

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
OHSU Knight Cancer Institute 200
Not applicableStudy completedNCT02199548
What this trial is testing

The Good Patient Study

Who this might be right for
Solid TumorHematological MalignanciesBrain Tumor
St. Jude Children's Research Hospital 43
Not applicableLooking for participantsNCT07679412
What this trial is testing

Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis.

Who this might be right for
CMV Retinitis
LucasBio 5
Very early researchUnknownNCT05707325
What this trial is testing

Safety, Tolerability and Preliminary Efficacy of Engineered Red Blood Cell in Patients With Advanced Malignancies

Who this might be right for
CancerSolid TumorHematologic Malignancy
Westlake Therapeutics 30
Early research (Phase 1)Ended earlyNCT02663518
What this trial is testing

A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors

Who this might be right for
Hematologic MalignanciesSolid Tumor
Pfizer 249
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Ended earlyNCT04789668
What this trial is testing

Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Hematopoietic and Lymphoid Cell Neoplasm+11 more
M.D. Anderson Cancer Center 8
Early research (Phase 1)Study completedNCT00720785
What this trial is testing

Natural Killer Cells and Bortezomib to Treat Cancer

Who this might be right for
Chronic Myeloid Leukemia (CML)Pancreatic CaColon/Rectal Ca+2 more
National Heart, Lung, and Blood Institute (NHLBI) 35
Not applicableActive Not RecruitingNCT05496972
What this trial is testing

Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation Oncology

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 200
Testing effectiveness (Phase 2)Ended earlyNCT00424645
What this trial is testing

Voraxaze for Delayed Methotrexate Clearance

Who this might be right for
Hematologic MalignancySolid Tumor
M.D. Anderson Cancer Center 3
Early research (Phase 1)Study completedNCT00002980
What this trial is testing

Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
California Cancer Consortium
Not applicableLooking for participantsNCT05022446
What this trial is testing

The Impact of COVID-19 on Pulmonary Procedures

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 250
Early research (Phase 1)Ended earlyNCT04272203
What this trial is testing

Determine Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose (RP2D) of Intravenous ABBV-184 in Adult Participants With Previously Treated Cancers

Who this might be right for
Acute Myeloid Leukemia (AML)Non Small Cell Lung CancerCancer
AbbVie 14
Next Page